Please login to the form below

Not currently logged in
Email:
Password:

American Diabetes Association

This page shows the latest American Diabetes Association news and features for those working in and with pharma, biotech and healthcare.

Alexa: find Novo Nordisk voice-activated diabetes tech

Alexa: find Novo Nordisk voice-activated diabetes tech

Alexa: find Novo Nordisk voice-activated diabetes tech. Hitlab challenge selects patient education firm Lighthouse for $50, 000 funding. ... The $50, 000 first prize was awarded in late 2017 to Lighthouse, which operates in partnership with the American

Latest news

  • Trial of J&J's canagliflozin boosts SGLT2 cardiovascular credentials Trial of J&J's canagliflozin boosts SGLT2 cardiovascular credentials

    The results of the CANVAS trial - presented at the American Diabetes Association meeting in San Diego - showed that Invokana (canagliflozin) reduced cardiovascular death, myocardial infarction and stroke by 14% compared to ... CANVAS also revealed that

  • Novo says real-world data backs its insulin switching Novo says real-world data backs its insulin switching

    The Danish drugmaker reported findings from its EU-TREAT patient registry study at the American Diabetes Association (ADA) meeting in San Diego on Saturday. ... EU-TREAT found that six months after switching haemoglobin A1c levels (a marker of blood

  • IBM plans Watson-powered 'diabetes advisor' IBM plans Watson-powered 'diabetes advisor'

    IBM plans Watson-powered 'diabetes advisor'. Teams up with the American Diabetes Association for big data collaboration. ... IBM Watson Health has teamed up with the American Diabetes Association (ADA) to build a first-of-its-kind 'diabetes advisor' for

  • Updated EMPA-REG data show Jardiance also protects kidney Updated EMPA-REG data show Jardiance also protects kidney

    placebo. The new results - presented at the American Diabetes Association (ADA) conference in New Orleans this week - also represent the first time that a drug in the SGLT2 inhibitor class has ... been shown to have a positive impact on kidney damage,

  • Victoza cuts cardiovascular risk in landmark study Victoza cuts cardiovascular risk in landmark study

    Victoza cuts cardiovascular risk in landmark study. Novo Nordisk’ s diabetes therapy outcomes ‘ beyond expectations’. ... The 9, 340-patient LEADER trial of Victoza (liraglutide) was presented at the American Diabetes Association (ADA) conference

More from news
Approximately 2 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Interview: Phil Southerland, Team Novo Nordisk Interview: Phil Southerland, Team Novo Nordisk

    It hit home at the American Diabetes Association conference this year, where I had a number of colleagues who said how much it meant to them how we were all type ... 1. It was proof that anything is possible even if you have diabetes.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics